Cangrelor Decreases Ischemia Driven Revascularization in Patients Undergoing Percutaneous Coronary Intervention: Evidence From a Meta-analysis of Randomized Trials

被引：0
|
作者：
Nairooz, Ramez [1 ]
Sardar, Partha [1 ]
Chatterjee, Suarav [2 ,3 ]
Mushiyev, Savi [1 ]
Pekler, Gerald [1 ]
Visco, Ferdinand [1 ]
机构：
[1] New York Metropolitan Hosp Cntr, New York, NY USA
[2] Brown Univ, Providence, RI 02912 USA
[3] Providence VA Med Ctr, Providence, RI USA
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Platelet receptor blockers; Acute coronary syndromes; Percutaneous coronary Intervention;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12336
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials
    Sardar, Partha
    Nairooz, Ramez
    Chatterjee, Saurav
    Mushiyev, Savi
    Pekler, Gerald
    Visco, Ferdinand
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (01) : 1 - 10
  • [2] Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials
    Partha Sardar
    Ramez Nairooz
    Saurav Chatterjee
    Savi Mushiyev
    Gerald Pekler
    Ferdinand Visco
    [J]. Journal of Thrombosis and Thrombolysis, 2014, 38 : 1 - 10
  • [3] Meta-Analysis of the Role of Cangrelor for Patients Undergoing Percutaneous Coronary Intervention
    Majmundar, Monil
    Kansara, Tikal
    Jain, Akash
    Shah, Palak
    Mithawala, Priyam
    Desai, Rupak
    Shah, Priyank
    Doshi, Rajkumar
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (07): : 1069 - 1075
  • [4] Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Hongtao Lu
    Wenjun Guan
    Yanhua Zhou
    Zhangui Tang
    Hong Bao
    [J]. Diabetes Therapy, 2019, 10 : 937 - 950
  • [5] Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Lu, Hongtao
    Guan, Wenjun
    Zhou, Yanhua
    Tang, Zhangui
    Bao, Hong
    [J]. DIABETES THERAPY, 2019, 10 (03) : 937 - 950
  • [6] Intravenous β-blockers for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials
    Elgendy, Islam Y.
    Elgendy, Akram Y.
    Mahmoud, Ahmed N.
    Mansoor, Hend
    Mojadidi, Mohammad K.
    Bavry, Anthony A.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 891 - 897
  • [7] Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials
    Verdoia, Monica
    Schaffer, Alon
    Barbieri, Lucia
    Suryapranata, Harry
    De Luca, Giuseppe
    [J]. THROMBOSIS RESEARCH, 2015, 135 (05) : 902 - 915
  • [8] Is Aspiration Thrombectomy Beneficial in Patients Undergoing Primary Percutaneous Coronary Intervention? Meta-Analysis of Randomized Trials
    Elgendy, Islam Y.
    Huo, Tianyao
    Bhatt, Deepak L.
    Bavry, Anthony A.
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (07)
  • [9] A network meta-analysis comparing cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention
    Westman, P. C.
    Lipinski, M.
    Torguson, R.
    Waksman, R.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 385 - 386
  • [10] An updated meta-analysis of randomized trials comparing complete versus culprit-only revascularization in patients undergoing primary percutaneous coronary intervention
    Colleran, Roisin
    Byrne, Robert
    Rai, Himanshu
    Voll, Felix
    Giacoppo, Daniele
    Cassese, Salvatore
    Joner, Michael
    Schunkert, Heribert
    Kastrati, Adnan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B210 - B210
12345